Literature DB >> 22430045

"Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?".

Philippe Moreau, S Vincent Rajkumar.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22430045     DOI: 10.1016/j.leukres.2012.02.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  Current approaches for the treatment of multiple myeloma.

Authors:  Reiko Watanabe; Michihide Tokuhira; Masahiro Kizaki
Journal:  Int J Hematol       Date:  2013-03-10       Impact factor: 2.490

Review 2.  Novel agents and new therapeutic approaches for treatment of multiple myeloma.

Authors:  Roberto Ria; Antonia Reale; Angelo Vacca
Journal:  World J Methodol       Date:  2014-06-26

3.  Is there an optimal timing of autologous stem-cell transplantation for multiple myeloma in the era of novel agents?

Authors:  Selami Koçak Toprak
Journal:  Turk J Haematol       Date:  2013-09-05       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.